Although it may be difficult to achieve the cure in mouse genetic models of SLE in which the cause of the disease—Lyn deficiency in this case—persists, we explored therapeutic conditions to attain a better effect of IRF5 inhibition. The gene discussed is IRF5; the disease is systemic lupus erythematosus.